跳至主要内容
临床试验/JPRN-UMIN000010422
JPRN-UMIN000010422已完成3 期

Clinical trial to evaluate efficacy and safety of KCS03 stent in a native coronary lesion - KCS03-1

Kaneka Corporation0 个研究点目标入组 115 人开始时间: 2013年4月8日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
115

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Cardiogenic shock (2)After cardiopulmonary resuscitation (3)LVEF is less than 25% (4)Previous every DES implantation or scheduled DES implantation within 6 months against target vessel or side branches (5)Every PCI procedures within prior 30 days against coronary arteries (6)ST elevated myocardial infarction (7)Cerebral stroke or TIA within prior 30 days (8)Acute or chronic renal insufficiency (creatinine is more than 2.0mg/dL.) (9)Active gastric ulcer or active gastrointestinal bleeding (10)Life expectation is less than 12 months. (11)Non-target lesion requiring treatment is located in the target vessel or side branches of the target vessel. (12)Any lesions are located in LMT. (13)Target lesion is located in a bypass graft. (14)Target lesion is located in the ostium of the vessel. (15)Moderate or severe calcification is observed in target lesion or proximal side of target lesion.

研究者

相似试验